Bone Biologics Corp Balance Sheet
BBLG|4 years of annual SEC 10-K data (FY2017-FY2020)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|
| Cash & Equivalents | - | $24.1K | $690.3K | $620.4K |
| Current Assets | - | $30.8K | $1.0M | $795.5K |
| PP&E (Net) | - | - | $50 | $146 |
| Total Assets | - | $30.8K | $1.0M | $795.7K |
| Current Liabilities | - | $578.4K | $9.6M | $961.8K |
| Shareholders' Equity | -$11.9M | -$8.6M | -$8.4M | -$8.4M |